Anti-Asthmatic Agent, Drug Exposure
dc.contributor.advisor | Spergel, Jonathan |
dc.contributor.advisor | Gabryszewski, Stan |
dc.contributor.author | Hirabayashi, Kathryn |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2024-09-24T19:50:49Z |
dc.date.available | 2024-06-10T19:03:37Z |
dc.date.created | 2024-05-03 |
dc.description | The new concept set contains asthma medications which include: combination medications (ICS and LABA), zileuton, theophylline, LTRA, LABA, ICS, SABA and Cromolyn, and asthma injections. The new concept set is a more comprehensive list (including descendants) of combination medications (ICS and LABA), zileuton, theophylline, LTRA, LABA, ICS, SABA and Cromolyn, and asthma injections. RxNorm and RxNorm extension codes and descendants were included. This medication list was partially based on an asthma severity computable phenotype published by Peer et al. (2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328264/). The full concept set was not reviewed (descendants caused the list to be very large), but Dr. Jonathan Spergel and Dr. Stan Gabryszewski reviewed the concepts used to generate the list. The concept set was generated to identify patients with an indication of atopic disease, including asthma, and to identify asthma severity based on asthma medications. |
dc.description.abstract | Broad concept set intended to identify patients with an exposure to an anti-asthmatic agent to identify patient asthma severity. |
dc.identifier.uri | https://hdl.handle.net/20.500.14642/642.2 |
dc.identifier.uri | https://doi.org/10.24373/pdsp-326.2 |
dc.provenance | The Researching COVID to Enhance Recovery (RECOVER) Post-Acute Sequelae of SARS-CoV-2 (PASC) Electronic Health Record (EHR) Cohort Study |
dc.publisher | PEDSnet |
dc.relation.uri | https://atlassian.chop.edu/bitbucket/projects/PASC/repos/team2_asthma/browse/exploratory.R#202-215 |
dc.rights | a CC-BY Attribution 4.0 License. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | Independent Variable |
dc.subject | Broad |
dc.subject.mesh | Adrenergic Receptor Agonist |
dc.subject.mesh | Sympathomimetic Agent |
dc.subject.mesh | Nonsteroidal Anti-inflammatory Drug |
dc.subject.mesh | Corticosteroid |
dc.subject.mesh | Receptor Agonist |
dc.subject.mesh | Anti-infective |
dc.subject.mesh | Hormone |
dc.subject.mesh | Steroid |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Anti-Asthmatic Agent, Drug Exposure |
dspace.entity.type | ConceptSet |
local.quality.status | Research-Ready |
local.subject.DataModel | PEDSnet Data Model |
local.subject.EvalType | Clinician Reviewed |
local.subject.MedTermChar | Brand Pack Name |
local.subject.MedTermChar | Semantic Branded Drug Form |
local.subject.MedTermChar | Semantic Clinical Drug Form |
local.subject.MedTermChar | Ingredient |
local.variable.name | rx_antiasthma |
relation.isConceptSetOfConceptSet | 5ea583e4-3717-471b-9e8d-342ad323fcf4 |
relation.isConceptSetOfConceptSet | 91fe63bb-b96f-4ab0-a58d-bf7724e04f80 |
relation.isConceptSetOfConceptSet.latestForDiscovery | 5ea583e4-3717-471b-9e8d-342ad323fcf4 |
relation.isStudyOfConceptSet | 4932bc8c-1f72-44ad-aeeb-b7922e38fad3 |
relation.isStudyOfConceptSet.latestForDiscovery | 4932bc8c-1f72-44ad-aeeb-b7922e38fad3 |
Files
Original bundle
1 - 1 of 1
Domains
Version History
You are currently viewing version 2 of the item.